CN
CNIE.XETRA VanEck New China ESG UCITS ETF A USD Acc
- EUR
No recent price
- Total assets
- 5.60M
- Expense ratio
- 0.58%
- Dividend yield
- -
- 1-year return
- -14.44%
- Holdings
- 10
- Since
- 2021
Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.
What does CNIE.XETRA invest in?
Tracks Morningstar China TME NR USD- Mostly Non-US stocks (100.0%)
- Largest sector: Healthcare (31.0%)
- Largest region: Asia Emerging (101.3%)
- Top 3 holdings: 3.6% of the fund
Asset allocation
- Non-US stocks 100.0%
- US stocks 0.9%
- Cash 0.4%
Top holdings
- WuXi Biologics 1.23%
- CSPC Pharmaceutical Group Ltd 1.21%
- Hansoh Pharmaceutical Group Co Ltd 1.15%
- Amlogic Shanghai Co Ltd 1.11%
- All Winner Technology Co Ltd 1.10%
VanEck New China ESG UCITS ETF A USD Acc performance
Sharpe ratio 0.02- This year
- -11.70%
- 1 year
- -14.44%
- 3 years
- +3.17%
- 5 years
- -5.53%
Volatility 12.5% over 1 year and 24.4% over 3 years. High: expect large swings.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
CNIE.XETRA price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
VanEck New China ESG UCITS ETF A USD Acc top holdings
11.1% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| WuXi Biologics 2269.HK | Healthcare | Hong Kong | 1.23% |
| CSPC Pharmaceutical Group Ltd 1093.HK | Healthcare | Hong Kong | 1.21% |
| Hansoh Pharmaceutical Group Co Ltd 3692.HK | Healthcare | Hong Kong | 1.15% |
| Amlogic Shanghai Co Ltd 688099.SHG | Technology | China | 1.11% |
| All Winner Technology Co Ltd 300458.SHE | Technology | China | 1.10% |
| CSPC Innovation Pharmaceutical Co Ltd Class A 300765.SHE | Consumer Defensive | China | 1.09% |
| Ningbo Menovo Pharm Co Ltd 603538.SHG | Healthcare | China | 1.07% |
| WuXi AppTec Co Ltd 603259.SHG | Healthcare | China | 1.07% |
| NetEase Inc 9999.HK | Communication Services | Hong Kong | 1.06% |
| Simcere Pharmaceutical Group Ltd 2096.HK | Healthcare | Hong Kong | 1.06% |
CNIE.XETRA sector exposure
- Healthcare31.0%
- Technology18.9%
- Consumer Cyclicals18.8%
- Consumer Defensive17.5%
- Communication Services8.9%
- Industrials5.2%
- Financial Services2.0%
Share of the stocks in the fund.
CNIE.XETRA regional exposure
- Asia Emerging101.3%
- North America0.9%
Share of the stocks in the fund.
Company size
Average market cap 7.83B- Mega cap11.0%
- Big cap33.3%
- Medium cap49.1%
- Small cap1.9%
VanEck New China ESG UCITS ETF A USD Acc fund profile
- Fund name
- VanEck New China ESG UCITS ETF A USD Acc
- Ticker
- CNIE.XETRA
- Exchange
- XETRA Stock Exchange
- Index tracked
- Morningstar China TME NR USD
- Category
- Greater China Equity
- Domicile
- Ireland
- Inception date
- Sep 24, 2021
- Trading currency
- EUR
- Expense ratio
- 0.58%